Celldex Therapeutics Inc (NAS:CLDX)
$ 36.92 0.6 (1.65%) Market Cap: 2.43 Bil Enterprise Value: 1.61 Bil PE Ratio: 0 PB Ratio: 2.90 GF Score: 62/100

Q4 2018 Celldex Therapeutics Inc Earnings Call Transcript

Mar 07, 2019 / 09:30PM GMT
Release Date Price: $4.6 (-1.71%)
Operator

Good day, ladies and gentlemen, and welcome to the Celldex Therapeutics Year-End 2018 Conference Call. (Operator Instructions) As a reminder, this call is being recorded.

I would now like to introduce your host for today's conference, Sarah Cavanaugh, Senior Vice President of Corporate Affairs. Ma'am, you may begin.

Sarah Cavanaugh
Celldex Therapeutics, Inc. - SVP of Corporate Affairs & Administration

Thank you. Good afternoon, and thank you for joining us. With me on the call today are Anthony Marucci, Cofounder, President and CEO of Celldex; Dr. Tibor Keler, Cofounder, Executive Vice President and Chief Scientific Officer; and Sam Martin, Senior Vice President and Chief Financial Officer.

Before we begin our discussion, I'd like to mention that today's speakers will be making forward-looking statements. Such statements reflect on current views with respect to certain -- to future events and are based on assumptions and subject to risks and uncertainties that could cause actual results to differ materially from those expressed or

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot